- Home
- DYN vs CCS Comparison
DYN vs CCS Comparison
Compare DYN & CCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DYN | CCS |
|---|---|---|
| Founded | 1984 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Homebuilding |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.9B |
| IPO Year | 2020 | 2014 |
Fundamental Metrics
Financial Performance| Metric | DYN | CCS |
|---|---|---|
| Price | $19.38 | $63.06 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 5 |
| Target Price | $40.25 | ★ $70.50 |
| AVG Volume (30 Days) | ★ 3.4M | 248.0K |
| Earning Date | 11-05-2025 | 01-28-2026 |
| Dividend Yield | N/A | ★ 1.84% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 6.93 |
| Revenue | N/A | ★ $4,157,669,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $8.74 |
| P/E Ratio | ★ N/A | $9.12 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.36 | $50.42 |
| 52 Week High | $27.59 | $85.98 |
Technical Indicators
Market Signals| Indicator | DYN | CCS |
|---|---|---|
| Relative Strength Index (RSI) | 47.95 | 54.26 |
| Support Level | $19.20 | $60.05 |
| Resistance Level | $20.80 | $64.43 |
| Average True Range (ATR) | 1.49 | 1.97 |
| MACD | -0.29 | 0.03 |
| Stochastic Oscillator | 20.70 | 48.58 |
Price Performance
Historical ComparisonAbout DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.
About CCS Century Communities Inc.
Century Communities Inc is engaged in the development, design, construction, marketing, and selling of single-family attached and detached homes. It has five homebuilding segments: West, Mountain, Texas, Southeast, and Century Complete. Its sixth reportable segment is financial services operations, which provides mortgage, title, and insurance services to homebuyers. It has acquired land for homebuilding operations with the primary intent to develop and construct single-family detached or attached homes for sale on the acquired land. The company sells homes through its sales representatives and independent real estate brokers. The company generates the majority of its revenue from the Mountain segment.